WHO ICTRP trial
Iron Deficiency in cardiac surgery
EUCTR2017-001823-26-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-001823-26-IT |
|---|---|
| Public title | Iron Deficiency in cardiac surgery |
| Scientific title | Efficacy and Safety of Intravenous Ferric Carboxymaltose in Patients Undergoing Cardiac Surgery A Randomized Controlled Study - IDECAS RCT 3.0 |
| Primary sponsor | UNIVERSITÀ CAMPUS BIO-MEDICO DI ROMA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | Iron deficiency in cardiac surgery MedDRA version: 20.0 Level: LLT Classification code 10067709 Term: Hypoferrism System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Trade Name: FERINJECT - 50 MG/ML SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO IN VETRO DA 20 ML Product Name: Ferinject Product Code: 40251074 Pharmaceutical Form: Concentrate for solution for injection INN or Proposed INN… |
| Registration date | Aug 6, 2021 |
| Target size | 50 |
| Secondary IDs | IDECASRCT;19032016 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: